{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:22:03Z","timestamp":1786119723835,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/iae.0b013e3181eef419","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T00:44:20Z","timestamp":1293065060000},"page":"724-729","source":"Crossref","is-referenced-by-count":27,"title":["ATHEROSCLEROTIC AND THROMBOPHILIC RISK FACTORS IN PATIENTS WITH ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION"],"prefix":"10.1097","volume":"31","author":[{"given":"Andrea","family":"Sodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Giambene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Fedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Menchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210130","first-page":"109","article-title":"Retinal vein occlusion.","volume":"42","author":"Hayreh","year":"1994","journal-title":"Indian J Ophthalmol"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0161-6420(83)34530-9","article-title":"Classification of central retinal vein occlusion.","volume":"90","author":"Hayreh","year":"1983","journal-title":"Ophthalmology"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.1993.01090080083022","article-title":"Baseline and early natural history report. The Central Vein Occlusion Study.","volume":"111","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0161-6420(95)30848-2","article-title":"A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N Report.","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion.","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archopht.1996.01100130537006","article-title":"Risk factors for central retinal vein occlusion.","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00055735-200012000-00013","article-title":"Systemic disorders associated with retinal vascular occlusion.","volume":"11","author":"Recchia","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0037-1616130","article-title":"Thrombophilic risk factors in patients with central retinal vein occlusion.","volume":"86","author":"Marcucci","year":"2001","journal-title":"Thromb Haemost"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(00)00709-1","article-title":"Systemic diseases associated with various types of retinal vein occlusion.","volume":"131","author":"Hayreh","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0953-6205(02)00025-0","article-title":"Cardiovascular and thrombophilic risk factors for central retinal vein occlusion.","volume":"13","author":"Prisco","year":"2002","journal-title":"Eur J Intern Med"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0002-9394(03)00571-3","article-title":"Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.","volume":"136","author":"Cahill","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1160\/TH03-08-0509","article-title":"Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.","volume":"92","author":"Gori","year":"2004","journal-title":"Thromb Haemost"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH04-11-0768","article-title":"Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.","volume":"93","author":"Janssen","year":"2005","journal-title":"Thromb Haemost"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1160\/TH07-04-0247","article-title":"Role of haemorheological factors in patients with retinal vein occlusion.","volume":"98","author":"Sofi","year":"2007","journal-title":"Thromb Haemost"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1167\/iovs.08-1826","article-title":"Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis.","volume":"49","author":"Cheung","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/00004872-200310000-00001","article-title":"Practice guidelines for primary care physicians: 2003 ESH\/ESC hypertension guidelines.","volume":"21","author":"Cifkova","year":"2003","journal-title":"Hypertension"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus.","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.ophtha.2005.05.019","article-title":"Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.","volume":"112","author":"Weger","year":"2005","journal-title":"Ophthalmology"},{"key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0181-5512(07)74029-9","article-title":"Assessment of risk factors for retinal vein occlusion in patients under 60 years of age.","volume":"30","author":"Salaun","year":"2007","journal-title":"J Fr Ophthalmol"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/bjo.2008.140640","article-title":"Prevalence and risk factors of retinal vein occlusion in an Asian population.","volume":"92","author":"Lim","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archopht.126.5.692","article-title":"Retinal vein occlusion and traditional risk factors for atherosclerosis.","volume":"126","author":"OMahoney","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11239-009-0384-5","article-title":"Retinal vein occlusion: evaluation of classic and emerging risk factors and treatment.","volume":"29","author":"Turello","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"R26-14-20210130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/112067210801800211","article-title":"Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion.","volume":"18","author":"Sodi","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"R27-14-20210130","first-page":"493","article-title":"Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.","volume":"98","author":"Vine","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R28-14-20210130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00001721-200210000-00007","article-title":"Central retinal vein occlusion and thrombophilia risk factors.","volume":"13","author":"Adamczuk","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R29-14-20210130","first-page":"249","article-title":"Retinal vein occlusion and hyperhomocysteinemia.","volume":"26","author":"Blondel","year":"2003","journal-title":"J Fr Ophthalmol"},{"key":"R30-14-20210130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0049-3848(03)00293-7","article-title":"Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.","volume":"110","author":"Marcucci","year":"2003","journal-title":"Thromb Res"},{"key":"R31-14-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000076144","article-title":"Hyperhomocysteinemia: a risk factor for retinal vein occlusion.","volume":"218","author":"Yildirim","year":"2004","journal-title":"Ophthalmologica"},{"key":"R32-14-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2004.06.084","article-title":"Homocysteine and retinal vein occlusion: a population-based study.","volume":"139","author":"Chua","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R33-14-20210130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1167\/iovs.06-0905","article-title":"Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population.","volume":"48","author":"Narayanasamy","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-14-20210130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1076029606296423","article-title":"Role of hyperhomocysteinemia in retinal vascular occlusive disease.","volume":"13","author":"Sottilotta","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"R35-14-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-9560-3-13","article-title":"Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B12 in patients with retinal vein occlusion.","volume":"3","author":"Ferrazzi","year":"2005","journal-title":"Thromb J"},{"key":"R36-14-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00006982-200601000-00011","article-title":"Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion.","volume":"26","author":"Lattanzio","year":"2006","journal-title":"Retina"},{"key":"R37-14-20210130","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1161\/STROKEAHA.107.486068","article-title":"B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort.","volume":"38","author":"Weikert","year":"2007","journal-title":"Stroke"},{"key":"R38-14-20210130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/eurheartj\/ehl470","article-title":"Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects.","volume":"28","author":"Vanuzzo","year":"2007","journal-title":"Eur Heart J"},{"key":"R39-14-20210130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/CIRCULATIONAHA.108.809038","article-title":"Plasma vitamin B6 and risk of myocardial infarction in women.","volume":"120","author":"Page","year":"2009","journal-title":"Circulation"},{"key":"R40-14-20210130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2796.2009.02077.x","article-title":"Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.","volume":"266","author":"Van Guelpen","year":"2009","journal-title":"J Intern Med"},{"key":"R41-14-20210130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2007.09.009","article-title":"Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels.","volume":"198","author":"Sofi","year":"2008","journal-title":"Atherosclerosis"},{"key":"R42-14-20210130","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"key":"R43-14-20210130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0038-1656059","article-title":"The mutation Ala-677-Val in the MTHFR gene: a risk factor for arterial disease and venous thrombosis.","volume":"77","author":"Arruda","year":"1997","journal-title":"Thromb Haemost"},{"key":"R44-14-20210130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.eye.6703061","article-title":"Homocysteine, folates, and the eye.","volume":"22","author":"Wright","year":"2008","journal-title":"Eye"},{"key":"R45-14-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bjo.67.3.137","article-title":"Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.","volume":"67","author":"Trope","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"R46-14-20210130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s003470170113","article-title":"Thrombophilia factors as inducers of retinal vascular occlusion.","volume":"98","author":"Lerche","year":"2001","journal-title":"Ophthalmologe"},{"key":"R47-14-20210130","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1055\/s-2004-813610","article-title":"Factor VIII activity in patients with central retinal vein occlusion in comparison to patients with a history of pelvic and lower limb venous thrombosis and a healthy control group.","volume":"221","author":"Faude","year":"2004","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R48-14-20210130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/107602960501100404","article-title":"Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion.","volume":"11","author":"Glueck","year":"2005","journal-title":"Clin Appl Thromb Hemost"},{"key":"R49-14-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3129\/i07-190","article-title":"Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid.","volume":"43","author":"Farahvash","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"R50-14-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2009.05.007","article-title":"Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study.","volume":"125","author":"Ageno","year":"2010","journal-title":"Thromb Res"},{"key":"R51-14-20210130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(07)60109-3","article-title":"Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial.","volume":"369","author":"Durga","year":"2007","journal-title":"Lancet"},{"key":"R52-14-20210130","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e3181eef419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:51:07Z","timestamp":1786042267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201104000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181eef419","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}